AI digital twins help manage diabetes and obesity

Silicon Valley startup Twin Health uses AI and wearable sensors as an alternative to expensive GLP-1 drugs for weight management. Retired firefighter Rodney Buckley lost 100 pounds in under a year through the program. His experience highlights a shift toward personalized health tech for chronic conditions.

As demand grows for cost-effective options beyond GLP-1 medications, companies like Twin Health are turning to artificial intelligence to support better health decisions. The startup employs digital twins—virtual models of individuals—and wearable sensors to guide users in managing diabetes and obesity.

Rodney Buckley, a 55-year-old retired firefighter and current village mayor of Third Lake, Illinois, joined the program last March when it was offered through his wife's employer. At that time, he weighed 376 pounds and had a history of unsuccessful dieting attempts, where he would lose weight only to regain it later. Without relying on GLP-1 drugs, Buckley achieved a 100-pound weight loss in less than a year using Twin Health's approach.

This method focuses on data-driven insights from wearables to encourage healthier choices, appealing to both patients and employers seeking sustainable solutions. The program's integration into workplace benefits underscores a broader trend in health care toward tech-enabled personalization for metabolic conditions.

相关文章

Athlete using sweat-sensing AI wearable for real-time, needle-free health monitoring of biomarkers like glucose and stress hormones in a lab setting.
AI 生成的图像

Study examines sweat-sensing AI wearables for early, needle-free health monitoring

由 AI 报道 AI 生成的图像 事实核查

Researchers at the University of Technology Sydney are exploring how sweat-sensing wearables, combined with artificial intelligence, could enable real-time, non-invasive tracking of health biomarkers. Their work suggests that sweat-based monitoring might one day help flag risks for conditions such as diabetes and other chronic diseases before symptoms appear, offering a painless complement to some blood tests for tracking hormones, medications, and stress-related biomarkers.

Health care company Abbott has introduced Libre Assist, a new AI-powered tool within its Libre app, designed to help people with diabetes assess the potential impact of their meals on glucose levels before eating. Users can simply photograph or describe their food to receive predictions and tips. The feature, unveiled at CES 2026, integrates with Abbott's FreeStyle Libre continuous glucose monitors for post-meal insights.

由 AI 报道

Apple is rethinking its plans for an AI-powered health coach, opting to release features individually rather than as a single package. The project, internally known as Mulberry or Health+, faces changes amid leadership shifts and competitive pressures. Individual tools, including videos and data recommendations, may still launch soon.

两名中国高位瘫痪患者成功使用脑机接口(BMI)技术,仅用意念控制动力轮椅、机器人狗取快递以及机械臂取杯饮水。这一突破于周三在上海中国科学院脑科学与智能技术卓越创新中心媒体通报会上公布,标志着BMI技术向实际临床应用迈进重大一步。

由 AI 报道

In 2025, Indians went beyond chasing weight loss or wellness hacks to renegotiate their relationships with food, medicine and their own bodies.

Utah has introduced a pilot program allowing artificial intelligence to refill prescriptions without human oversight, marking a significant step in medical innovation. The initiative, partnered with telehealth startup Doctronic, targets common medications for chronic conditions amid concerns over safety and regulation. Public advocates have labeled the program dangerous due to its potential risks.

由 AI 报道

The US Department of Health and Human Services is creating a generative AI tool to analyze vaccine injury claims. The tool aims to identify patterns in a national monitoring database and generate hypotheses on vaccine side effects. Experts express concerns about its potential use under Robert F. Kennedy Jr.'s leadership.

 

 

 

此网站使用 cookie

我们使用 cookie 进行分析以改进我们的网站。阅读我们的 隐私政策 以获取更多信息。
拒绝